IONTOX is now part of LifeNet Health LifeSciences

IONTOX has joined LifeNet Health LifeSciences. We will continue offering the same great in vitro assay services — now with even more ways to support your research. Learn more.

Download the In Vitro Services Catalog


IONTOX works with a global client base on ADME-PK and toxicology based in vitro research.

In 2013 the Editor and Chief of Applied In Vitro Toxicology James McKim, Ph.D., D.A.B.T., founded IONTOX to support his contacts in the pharmaceutical, chemical, food additive, and cosmetic industries.

IONTOX follows GIVIMP and GCCP guidelines.

Advanced In Vitro Research

Do advanced in vitro research

Organ Specific Toxicity

Identify adverse outcome pathways of a specific organ in vitro.

Learn More

IDILI Liability

Understand a compounds liability to cause idiosyncratic drug injury.

Learn More

Multiple Organ Studies

Link organ models together to understand systemic toxicity.

Learn More


Study cell toxicity

Cell Viability

Assays to identify cell viability.

Learn More


Assay to assess mitochondrial toxicity.

Learn More

Cytotoxicity Panel

Assays for in vitro to in vivo extrapolation.

Learn More

ADME -PK In Vitro

Study Absorption, distribution, metabolism, excretion, and pharmacokinetics.

IND Enabling

Assays required by the FDA for an investigational new drug.

Learn More

New Chemical Registration

Assays to support research for New Chemical Registration.

Learn More

Standard ADME-PK

Gold standard assays for understanding the ADME of a compound.

Learn More

3D Tissue Testing

Study how your compound effects advanced 3D tissue models.

Ocular Irritation

Screen compounds for ocular irritation with advanced 3D models.

Learn More

Dermal Irritation

Screen compounds for dermal irritation with advanced 3D models.

Learn More

Dermal Corrosion

Screen compounds for dermal corrosion with advanced 3D models.

Learn More

Our Products